At a glance
ClinicalIndex Comparison RecordN/ACompleted· 67 enrolled
Drug / intervention
AngioPress Intermittent pneumatic compression (IPC) Device +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Randomized, Multi-center Clinical Trial to Evaluate the Efficacy and Safety of a New Intermittent Pneumatic Compression Device on Initial Claudication Distance in Patients With Peripheral Arterial Disease Stage II.
In Brief
A clinical study evaluating AngioPress Intermittent pneumatic compression (IPC) Device and Medications and Standard walking exercises for Peripheral Arterial Disease. Completed, enrolled 67 participants across 4 sites in 2 countries.
Detailed Summary
The purpose of this study is to evaluate the safety and efficacy of new intermittent pneumatic compression device on initial claudication distance in patients with Peripheral Arterial Disease stage II
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Arterial Disease
CountriesGermany, Israel
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 2008
Enrollment StartMar 2009
Primary CompletionJan 2012
TodayJul 2026
First PostedSep 30, 2008
Enrollment StartMar 1, 2009
Primary CompletionJan 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 17.8 years ago
Interventions
AngioPress Intermittent pneumatic compression (IPC) Devicedevice
Treatment with Intermittent pneumatic compression (IPC) for PAD
Medications and Standard walking exercisesother
Aspirin/Clopidegrol and Standard walking exercises